• Adults​ ​With​ ​Muscular Dystrophy

  FDA Awards $1M to Duchenne MD Phase 2 Study of Ifetroban in Treating Related Heart Disease

  Posted by md-forums-moderator on October 4, 2019 at 11:58 am

  The $1 million grant to Cumberland Pharmaceuticals is going to support a soon-to-open 12-month trial of oral ifetroban in DMD patients with heart muscle damage. Click here to read the whole story.

  Are you excited about this news?

  md-forums-moderator replied 4 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply